Daniel Gardner
Family · Daphne, ALNPI 1275913279
Payments from drug & device makers
Across 589 payments — averaging $21.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$2K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Regeneron Healthcare Solutions, Inc.$1K
- Sanofi$1K
- Genentech USA, Inc.$931
- plus $4K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 94 | $2,274 |
| GSK | 107 | $1,524 |
| Takeda Pharmaceuticals U.S.A., Inc. | 52 | $1,401 |
| Regeneron Healthcare Solutions, Inc. | 55 | $1,398 |
| Sanofi | 43 | $1,023 |
| Genentech USA, Inc. | 39 | $931 |
| CSL Behring | 27 | $710 |
| Amgen | 15 | $375 |
| Grifols USA, LLC | 12 | $269 |
| Optinose US, Inc. | 13 | $268 |
| Incyte Corporation | 11 | $240 |
| Novartis | 11 | $231 |
| Boehringer Ingelheim | 15 | $223 |
| Pfizer | 11 | $212 |
| Kaleo, Inc. | 10 | $190 |
| Biocryst US Sales Co., LLC | 8 | $188 |
| Verona Pharma, Inc. | 7 | $147 |
| Mylan Specialty L.p. | 9 | $146 |
| AbbVie | 5 | $145 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $139 |
| Axsome Therapeutics, Inc. | 2 | $113 |
| Viatris Specialty LLC | 6 | $109 |
| Lilly USA, LLC | 5 | $92 |
| Philips North America LLC | 3 | $81 |
| LEO Pharma Inc. | 4 | $75 |
| Organon | 6 | $53 |
| Aytu Biopharma, Inc. | 2 | $51 |
| Alk-abello, Inc | 3 | $48 |
| Merck | 2 | $40 |
| Hikma Pharmaceuticals USA | 2 | $29 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| Ionis Pharmaceuticals, Inc. | 1 | $22 |
| Blueprint Medicines Corporation | 1 | $21 |
| Phadia US Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
How this compares
$12,823 in reported general payments places this provider in the 95th percentile of 3,415 family providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in Daphne
- Nina HibbardDaphne$12K
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.